Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Liver Cirrhosis

  Free Subscription


Articles published in Clin Res Hepatol Gastroenterol

Retrieve available abstracts of 35 articles:
HTML format
Text format



Single Articles


    March 2017
  1. JAMSHIDZADEH A, Heidari R, Latifpour Z, Ommati MM, et al
    Carnosine ameliorates liver fibrosis and hyperammonemia in cirrhotic rats.
    Clin Res Hepatol Gastroenterol. 2017 Mar 7. pii: S2210-7401(17)30009.
    PubMed     Text format     Abstract available


    February 2017
  2. LI K, Liu H, Guo T
    Th17/Treg imbalance is an indicator of liver cirrhosis process and a risk factor for HCC occurrence in HBV patients.
    Clin Res Hepatol Gastroenterol. 2017 Feb 3. pii: S2210-7401(17)30003.
    PubMed     Text format     Abstract available


    December 2016
  3. ZHENG L, Qin J, Sun L, Gui L, et al
    Intrahepatic upregulation of MRTF-A signaling contributes to increased hepatic vascular resistance in cirrhotic rats with portal hypertension.
    Clin Res Hepatol Gastroenterol. 2016 Dec 30. pii: S2210-7401(16)30203.
    PubMed     Text format     Abstract available


    August 2016
  4. FONTAINE H, Maynard M, Bouix C, Carrieri MP, et al
    Efficacy and safety of boceprevir-based triple therapy in HCV cirrhotic patients awaiting liver transplantation (ANRS HC29 BOCEPRETRANSPLANT).
    Clin Res Hepatol Gastroenterol. 2016 Aug 20. pii: S2210-7401(16)30098.
    PubMed     Text format     Abstract available


    July 2016
  5. TAS A, Olmez S, Yalcin MS
    A rare cause of elevated alpha fetoprotein in patient with cirrhosis.
    Clin Res Hepatol Gastroenterol. 2016 Jul 5. pii: S2210-7401(16)30084.
    PubMed     Text format    


    May 2016
  6. WOSIEWICZ P, Zorniak M, Hartleb M, Baranski K, et al
    Portal vein thrombosis in cirrhosis is not associated with intestinal barrier disruption or increased platelet aggregability.
    Clin Res Hepatol Gastroenterol. 2016 May 5. pii: S2210-7401(16)30048.
    PubMed     Text format     Abstract available


    April 2016
  7. LIU L, Zhang C, Hu Y, Zhou L, et al
    Changes in gut toll-like receptor-4 and nod-like receptor family pyrin domain containing-3 innate pathways in liver cirrhosis rats with bacterial translocation.
    Clin Res Hepatol Gastroenterol. 2016 Apr 6. pii: S2210-7401(16)30038.
    PubMed     Text format     Abstract available


  8. INGILIZ P, Mayr C, Obermeier M, Herbst H, et al
    Persisting hepatitis E virus infection leading to liver cirrhosis despite recovery of the immune system in an HIV-infected patient.
    Clin Res Hepatol Gastroenterol. 2016 Apr 4. pii: S2210-7401(16)30033.
    PubMed     Text format     Abstract available


    January 2016
  9. ZHU Q, Yuan B, Qiao GL, Yan JJ, et al
    Prognostic factors for survival after hepatic resection of early hepatocellular carcinoma in HBV-related cirrhotic patients.
    Clin Res Hepatol Gastroenterol. 2016 Jan 25. pii: S2210-7401(15)00298.
    PubMed     Text format     Abstract available


    November 2015
  10. RASZEJA-WYSZOMIRSKA J, Wunsch E, Krawczyk M, Rigopoulou EI, et al
    Assessment of health related quality of life in polish patients with primary biliary cirrhosis.
    Clin Res Hepatol Gastroenterol. 2015 Nov 24. pii: S2210-7401(15)00260.
    PubMed     Text format     Abstract available


  11. WANG J, Liu Y, Xie L, Li S, et al
    Association of IL-17A and IL-17F gene polymorphisms with chronic hepatitis B and hepatitis B virus-related liver cirrhosis in a Chinese population: A case-control study.
    Clin Res Hepatol Gastroenterol. 2015 Nov 3. pii: S2210-7401(15)00258.
    PubMed     Text format     Abstract available


    October 2015
  12. HASTIER A, Patouraux S, Canivet CM, Lebeaupin C, et al
    Nonalcoholic steatohepatitis cirrhosis and type 1 refractory celiac disease: More than a fortuitous association?
    Clin Res Hepatol Gastroenterol. 2015 Oct 29. pii: S2210-7401(15)00249.
    PubMed     Text format    


  13. BEUERS U, Gershwin ME, Gish RG, Invernizzi P, et al
    Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'.
    Clin Res Hepatol Gastroenterol. 2015;39:e57-9.
    PubMed     Text format    


    July 2015
  14. BERENGUER M
    Management of HCV in the liver transplant setting.
    Clin Res Hepatol Gastroenterol. 2015 Jul 20. pii: S2210-7401(15)00114.
    PubMed     Text format     Abstract available


  15. MACHADO MV, Cortez-Pinto H
    Proangiogenic factors in the development of HCC in alcoholic cirrhosis.
    Clin Res Hepatol Gastroenterol. 2015 Jul 17. pii: S2210-7401(15)00131.
    PubMed     Text format     Abstract available


  16. ZHU W, Chang-Li L, Mao-Yao W, Li Y, et al
    Persistent abnormal liver function tests may predict development of cirrhosis in chronic hepatic graft-versus-host disease.
    Clin Res Hepatol Gastroenterol. 2015 Jul 13. pii: S2210-7401(15)00143.
    PubMed     Text format    


    June 2015
  17. KAYADIBI H, Sertoglu E, Uyanik M
    Clinical situations that lead to misinterpretation of indirect biochemical indexes in liver diseases.
    Clin Res Hepatol Gastroenterol. 2015;39:e41-2.
    PubMed     Text format    


    May 2015
  18. QI X, Su C, Ren W, Yang M, et al
    Association between portal vein thrombosis and risk of bleeding in liver cirrhosis: A systematic review of the literature.
    Clin Res Hepatol Gastroenterol. 2015 May 5. pii: S2210-7401(15)00081.
    PubMed     Text format     Abstract available


    April 2015
  19. PETIT MA, Berthillon P, Pradat P, Arnaud C, et al
    Anti-E1E2 antibodies do predict response to triple therapy in treatment-experienced Hepatitis C Virus-cirrhosis cases.
    Clin Res Hepatol Gastroenterol. 2015 Apr 17. pii: S2210-7401(15)00075.
    PubMed     Text format     Abstract available


  20. GRIGORIAN AY, Mardini HE, Corpechot C, Poupon R, et al
    Fenofibrate is effective adjunctive therapy in the treatment of primary biliary cirrhosis: A meta-analysis.
    Clin Res Hepatol Gastroenterol. 2015 Apr 13. pii: S2210-7401(15)00077.
    PubMed     Text format     Abstract available


  21. MANENTI A, Pavesi E, Farinetti A, Colasanto D, et al
    For a better morpho-dynamic evaluation of the portal system in cirrhosis.
    Clin Res Hepatol Gastroenterol. 2015 Apr 7. pii: S2210-7401(15)00045.
    PubMed     Text format    


  22. MA JQ, Ding J, Zhang L, Liu CM, et al
    Protective effects of ursolic acid in an experimental model of liver fibrosis through Nrf2/ARE pathway.
    Clin Res Hepatol Gastroenterol. 2015;39:188-97.
    PubMed     Text format     Abstract available


    January 2015
  23. BAILLY F, Virlogeux V, Dufour C, Pradat P, et al
    Early virological assessment during telaprevir- or boceprevir-based triple therapy in hepatitis C cirrhotic patients who failed a previous interferon based regimen - The ANRS CO20-CUPIC study.
    Clin Res Hepatol Gastroenterol. 2015 Jan 27. pii: S2210-7401(15)00002.
    PubMed     Text format     Abstract available


  24. MAO W, Hu Y, Lou Y, Dou J, et al
    Immature platelet fraction values predict recovery of platelet counts following liver transplantation.
    Clin Res Hepatol Gastroenterol. 2015 Jan 12. pii: S2210-7401(14)00294.
    PubMed     Text format     Abstract available


    December 2014
  25. ZHOU HY, Chen TW, Zhang XM, Jing ZL, et al
    Patterns of portosystemic collaterals and diameters of portal venous system in cirrhotic patients with hepatitis B on magnetic resonance imaging: Association with Child-Pugh classifications.
    Clin Res Hepatol Gastroenterol. 2014 Dec 5. pii: S2210-7401(14)00250.
    PubMed     Text format     Abstract available


    November 2014
  26. TAM N, Zhang C, Lin J, Wu C, et al
    Simultaneous pancreas and kidney transplantation for liver transplant recipients with diabetes and uremia.
    Clin Res Hepatol Gastroenterol. 2014 Nov 4. pii: S2210-7401(14)00244.
    PubMed     Text format     Abstract available


    September 2014
  27. HIMOTO T, Tanaka N, Saito A, Muro Y, et al
    Diversity of humoral responses to the centromere proteins among HCV-related chronic liver disease, PBC and AIH patients.
    Clin Res Hepatol Gastroenterol. 2014 Sep 11. pii: S2210-7401(14)00184.
    PubMed     Text format     Abstract available


    August 2014
  28. POUJOL-ROBERT A, Boelle PY, Conti F, Durand F, et al
    Aspirin may reduce liver fibrosis progression: Evidence from a multicenter retrospective study of recurrent hepatitis C after liver transplantation.
    Clin Res Hepatol Gastroenterol. 2014 Aug 14. pii: S2210-7401(14)00166.
    PubMed     Text format     Abstract available


    June 2014
  29. KARAGOZ E, Tanoglu A
    Prognostic role of mean platelet volume in patients with chronic hepatitis C.
    Clin Res Hepatol Gastroenterol. 2014 Jun 19. pii: S2210-7401(14)00096.
    PubMed     Text format    


  30. PERAZZO H, Pais R, Munteanu M, Ngo Y, et al
    Variability in definitions of transaminase upper limit of the normal impacts the APRI performance as a biomarker of fibrosis in patients with chronic hepatitis C: "APRI c'est fini ?"
    Clin Res Hepatol Gastroenterol. 2014 Jun 9. pii: S2210-7401(14)00101.
    PubMed     Text format     Abstract available


    April 2014
  31. JANG W, Yu SI, Sinn DH, Park SH, et al
    Longitudinal change of liver stiffness by transient elestography in chronic hepatitis B patients treated with nucleos(t)ide analogue.
    Clin Res Hepatol Gastroenterol. 2014;38:195-200.
    PubMed     Text format     Abstract available


    March 2014
  32. DUMORTIER J, Salame E, Roche B, Hurtova M, et al
    Severe fibrosis in patients with recurrent hepatitis C after liver transplantation: A French experience on 250 patients over 15 years (the Orfevre study).
    Clin Res Hepatol Gastroenterol. 2014 Mar 28. pii: S2210-7401(14)00051.
    PubMed     Text format     Abstract available


    February 2014
  33. DEMIROREN K, Dogan Y, Kocamaz H, Ozercan IH, et al
    Protective effects of L-carnitine, N-acetylcysteine and genistein in an experimental model of liver fibrosis.
    Clin Res Hepatol Gastroenterol. 2014;38:63-72.
    PubMed     Text format     Abstract available


  34. NAKANUMA Y
    Primary biliary cirrhosis: is there still a place for histological evaluation?
    Clin Res Hepatol Gastroenterol. 2014;38:e1-2.
    PubMed     Text format    


    October 2013
  35. BARBIER L , Hardwigsen J, Borentain P, Biance N, et al
    Impact of transjugular intrahepatic portosystemic shunting on liver transplantation: 12-year single-center experience.
    Clin Res Hepatol Gastroenterol. 2013 Oct 29. pii: S2210-7401(13)00191.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Cirrhosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: